ExpreS2ion Biotech Holding AB (EXPRS2) — Financial Flexibility Index
ExpreS2ion Biotech Holding AB (EXPRS2) has a Financial Flexibility Index of 0.02x as of December 2025. Free cash flow of Skr684.00K (operating CF Skr684.00K minus capex Skr0.00) represents 0% of total liabilities (Skr29.42 Million). Also explore EXPRS2 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ExpreS2ion Biotech Holding AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for ExpreS2ion Biotech Holding AB across 10 annual periods. Check EXPRS2 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ExpreS2ion Biotech Holding AB (2016–2025)
Year-by-year free cash flow to debt coverage for ExpreS2ion Biotech Holding AB. For the full company profile including market capitalisation, see EXPRS2 company net worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.39x | Skr-40.90 Million | Skr-40.90 Million | Skr29.42 Million | ▼ -68.7% |
| 2024 | -0.82x | Skr-33.06 Million | Skr-33.93 Million | Skr40.11 Million | ▲ +88.9% |
| 2023 | -7.42x | Skr-98.87 Million | Skr-100.89 Million | Skr13.33 Million | ▼ -154.4% |
| 2022 | -2.92x | Skr-99.23 Million | Skr-99.61 Million | Skr34.04 Million | ▲ +24.7% |
| 2021 | -3.87x | Skr-44.93 Million | Skr-45.65 Million | Skr11.61 Million | ▼ -444.1% |
| 2020 | -0.71x | Skr-17.29 Million | Skr-18.18 Million | Skr24.31 Million | ▼ -17.2% |
| 2019 | -0.61x | Skr-12.01 Million | Skr-12.69 Million | Skr19.79 Million | ▲ +36.3% |
| 2018 | -0.95x | Skr-12.07 Million | Skr-12.88 Million | Skr12.65 Million | ▼ -19.1% |
| 2017 | -0.80x | Skr-8.40 Million | Skr-8.61 Million | Skr10.50 Million | ▼ -49.1% |
| 2016 | -0.54x | Skr-6.30 Million | Skr-7.02 Million | Skr11.73 Million | — |